BIOCRYST PHARMACEUTICALS INC

Ticker: BCRX CUSIP: 09058V103 Class: Common Stock

AlphaCentric Advisors LLC's Holding History (CIK: 0001913464)

Note: Option positions (PUT/CALL) are excluded.

Q2 2024
Shares 675,000 Value ($000) $4,172 Avg Close $5.52 Range $4.03 - $6.99
Q1 2024
Shares 675,000 Value ($000) $3,429 Avg Close $5.62 Range $4.82 - $7.75
Q4 2023
Shares 675,000 Value ($000) $4,043 Avg Close $5.79 Range $4.83 - $7.06
Q3 2023
Shares 649,000 Value ($000) $4,595 Avg Close $7.18 Range $6.62 - $7.95
Q2 2023
Shares 570,000 Value ($000) $4,013 Avg Close $8.02 Range $6.87 - $9.07
Q1 2023
Shares 419,500 Value ($000) $3,499 Avg Close $9.63 Range $7.82 - $12.08
Q4 2022
Shares 125,000 Value ($000) $1,435 Avg Close $12.47 Range $10.36 - $14.50
Q3 2022
Shares 70,000 Value ($000) $882 Avg Close $12.87 Range $10.33 - $15.43
Q4 2021
Shares 17,500 Value ($000) $242 Avg Close $13.23 Range $10.72 - $15.77